Q3 2020 Holdings
Filed 2020-11-16 | 45 holdings | $553.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $169.0M | 5,840,107 | 30.5% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $90.3M | 620,000 | 16.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $61.3M | 1,750,000 | 11.1% |
| Codexis Inc(CDXS) | COM | 192005106 | $46.8M | 3,985,000 | 8.4% |
| Caredx Inc(CDNA) | COM | 14167L103 | $45.3M | 1,193,335 | 8.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $43.0M | 150,000 | 7.8% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $35.6M | 945,000 | 6.4% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $34.7M | 713,125 | 6.3% |
| Alector Inc(ALEC) | COM | 014442107 | $17.4M | 1,650,000 | 3.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $8.7M | 289,395 | 1.6% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $391.6K | 9,033,943 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $162.2K | 3,808,894 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $143.7K | 1,550,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $121.9K | 3,050,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $118.6K | 870,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $76.0K | 1,000,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $74.4K | 530,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $56.9K | 1,634,535 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $49.8K | 1,611,214 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $49.4K | 915,000 | 0.0% |
| Burning Rock Biotech LTD | SPONSORED ADS | 12233L107 | $48.2K | 1,922,150 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $46.9K | 1,310,000 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $44.4K | 4,500,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $28.3K | 2,750,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $22.8K | 3,346,034 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $22.3K | 266,430 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $21.8K | 395,000 | 0.0% |
| Amyris Inc(AMRSEUR) | COM NEW | 03236M200 | $21.6K | 7,390,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $19.9K | 980,000 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $18.4K | 820,440 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $17.1K | 1,428,572 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $15.8K | 190,000 | 0.0% |
| Berkeley LTS Inc(BLIUSD) | COM | 084310101 | $15.3K | 200,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT 99/99/9999 | 110122157 | $14.1K | 6,250,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $11.4K | 1,441,176 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $10.2K | 1,080,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $9.5K | 290,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $9.3K | 30,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $7.7K | 1,870,000 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.5K | 370,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $6.6K | 75,000 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $6.3K | 251,515 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $4.3K | 139,661 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $4.0K | 120,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $3.3K | 65,000 | 0.0% |